Lovastatin enhances chemosensitivity of paclitaxel-resistant prostate cancer cells through inhibition of CYP2C8
2022 ◽
Vol 589
◽
pp. 85-91
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):